Navigation Links
GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
Date:2/25/2008

ATLANTA, Feb. 25 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), http://www.geovax.com, an Atlanta based biotechnology company, announced their HIV/AIDS vaccine is one of the select few to move forward into Phase 2a human trials by the HIV Vaccine Trials Network (HVTN), a network supported by the National Institutes of Health (NIH).

GeoVax's AIDS vaccine is believed to be only the fifth [5th] HIV/AIDS vaccine to be selected to move forward into Phase 2a human trials conducted by the HVTN. In contrast, it was approximately HVTN's 65th vaccine evaluated in Phase 1 human trials.

Most recently, GeoVax Senior Vice President of Research & Development, Dr. Harriet Robinson, and President, Don Hildebrand, attended a meeting with key HTVN officials in Seattle, Washington to plan and prepare necessary documents for the next phase of testing of GeoVax's promising HIV/AIDS vaccine, namely Phase 2a human trials designated as Protocol # HVTN 205.

Attended by over 20 HVTN personnel and key GeoVax personnel, this event included individuals instrumental in organizing and implementing human clinical trials designed to evaluate the GeoVax HIV/AIDS vaccine. The newly planned Phase 2 trials are tentatively scheduled to start mid-2008 and will involve up to 500 participants at several locations in the USA.

"We are delighted that our HIV/AIDS vaccine has been selected to move forward into Phase 2 trials. Our vaccine continues to demonstrate the promise of not only being safe but also effective at eliciting potentially protective immune responses," stated Dr Harriet Robinson, Senior Vice President, Research & Development at GeoVax.

"GeoVax is extremely pleased to have passed the significant hurdles required to move into Phase 2 trials. Only a handful of AIDS vaccines have reached the Phase 2 level of clinical evaluation with the HVTN, including the previously failed vaccines
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
2. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
3. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
6. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
7. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
8. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
9. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
10. Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
11. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015  Rigrodsky & Long, P.A.: , Do you, ... AERI )? , Did you purchase your shares between ... you lose money in your investment in Aerie Pharmaceuticals, Inc.? ... Rigrodsky & Long, P.A. , including former Special Assistant ... complaint has been filed in the United States District Court for ...
(Date:5/6/2015)... STOCKHOLM and PRETORIA, South Africa ... Africa , cancer kills more people than HIV/AIDS, malaria ... be prevented[2] and 40 percent can be cured with the ... a dozen African nations are working to build up their ... 50 percent of all cancer patients worldwide would benefit from ...
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... "Energy based Ablation Devices - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of World. ... through 2020. Also, a seven-year historic analysis is provided for ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... LigoCyte Pharmaceuticals,Inc., today announced a strategic partnership ... targeting CD103 for the treatment of chronic,inflammatory ... CD103 is the unique alphaE-beta7 integrin that,has ... retention of lymphocytes,that mediate inflammatory diseases affecting ...
... be webcast live at http://www.wilsoncenter.org/globalhealth , WASHINGTON, ... called for a reauthorization of the President,s,Emergency Plan for ... the end,of fiscal year 2008. The plan calls for ... $15 billion to $30 billion over the next five,years., ...
Cached Medicine Technology:Director's Forum: PEPFAR and the Global AIDS Response 2
(Date:5/6/2015)... Mass. (PRWEB) May 06, 2015 ... today announced that CTO David Ting will lead a ... the associated data security and user authentication challenges, during ... Fla.). The session will focus on the benefits of ... in which care providers and patients can share information. ...
(Date:5/6/2015)... A quality built chicken coop condo with a ... way to raise chickens on a pasture. By installing a ... will have a chicken tractor that stands up to being moved ... as it is able to flex to uneven ground without losing ... land are fertilized, and it will help provide the chickens with ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Corporate ... behalf of MEBC, an Alliance Award for excellence ... during FOCUS 2015, JDA’s annual user conference which ... retail and wholesale distribution sectors. This award recognizes ... are receiving services that advance their supply chain ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... King of Prussia, PA (PRWEB) May 06, 2015 ... Business Process Outsourcing solutions to the Medicare Advantage, Medicare ... three finalists in the Continuity and Resilience Team category ... by the Business Continuity Institute to recognize the outstanding ... or operating in the North America Region, including the ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... shows a laugh signifies more than humor and ridicule, ... // of the role of laughter during psychotherapy. ... than about humor. Researchers videotaped therapeutic sessions and took ... where patients were being treated for outpatient mood and ...
... weight loss surgery should probably be tested to see ... disorders, say researchers according to findings of a recent ... and has also been linked to stomach cancer. However ... people undergoing gastric bypass surgery a weight loss operation ...
... 60 are affected by Parkinson’s disease. The condition is characterized ... from loss of facial rigidity // and a shuffling walk. ... of Parkinson’s disease may also be able to stop its ... found to completely halt the neurotoxic effects of a chemical ...
... increase ones risk for breast cancer. A recent study ... for one year experienced a two-fold increase in breast ... risk of having an abnormal mammogram was four-times greater, ... ages 50 and 79. The average woman was 62 ...
... the risk of developing liver cancer and more than ... researchers based on findings of a recent study. ... with 12 different types of cancer to 509 healthy ... of diabetes were more likely to be diagnosed with ...
... of alcohol may increase the risk of developing an ... men and women. Participants were given questionnaires that assessed ... they consumed. It was found that men consumed an ... while the women consumed about 14 grams. ,During ...
Cached Medicine News:
Designed for rapid, routine electrophoresis for nucleic acids. The Mini unit is designed with a choice of two casting systems: standard casting trays that require sealing tape; or aluminum-gated cast...
... Wide mini horizontal gel system is designed for very ... agarose gels. This System allows the user to cast, ... quality. Complete system with : 1 x electrophoresis tank ... MT-T01 (105 x 83 mm tray), 2 x MT-T02 ...
... Hoefer offers the HE 33 Mini Submarine Unit for ... HE 33 is designed for very fast separations of ... base acts as a heat-sink. Fill the base with ... run, by either keeping the unit in a freezer ...
... The SEA 2000 Electrophoresis Apparatus (patented) ... your DNA and RNA electrophoresis., In combination ... SEA 2000 covers applications that require a ... bed system., With the SEA 2000 it ...
Medicine Products: